. 5 That change in treatment guidelines was adopted in the face of new evidence that early ART improves patients' health and has the potential to diminish HIV transmission. 6, 7 The emphasis on early treatment codified in the guidelines is also evident in the US National HIV/AIDS Strategy, and the more recent HIV Care Continuum Initiative. 8 All of these documents focus on the HIV care continuum-the sequential steps from HIV diagnosis, to linkage and retention in care, ART initiation, and viral suppression [9] [10] [11] [12] -and all emphasize the importance of identifying persons with HIV infection shortly after HIV acquisition and rapidly achieving the goal of viral suppression.
We previously published data on the HIV care continuum in King County, WA, demonstrating that 67% to 75% of all diagnosed persons with HIV infection are virally suppressed. 13, 14 This cross-sectional evaluation is a measure of the success of the HIV prevention and care system in King County, but provides relatively little insight into the system's success in meeting the needs of persons with recently diagnosed HIV infection, and accelerating progress along the HIV care continuum. Here we present data on trends in the time from diagnosis to viral suppression among persons diagnosed as having HIV infection in King County, WA, from 2007 to 2013, demonstrating that our local care system has rapidly responded to new scientific evidence, treatment guidelines, and public health initiatives that emphasize early linkage to care and initiation of ART.
MATERIALS AND METHODS
We examined the time from HIV diagnosis to viral suppression among persons diagnosed as having HIV infection in King County, WA, from 2007 to 2013. The work was conducted at the Public Health-Seattle & King County HIV/AIDS Epidemiology section and included the period after all CD4 and viral loads became legally reportable (mid-2006) . Participants included all HIV-infected individuals older than 14 years diagnosed between 2007 and 2013 who resided in King County at the time of diagnosis and were reported to Public Health-Seattle & King County as of June 4, 2015 . Individuals known to be enrolled in research studies were not included in this analysis because WA State law excludes research studies from HIV laboratory reporting requirements. Study status is ascertained through provider and patient contact either during surveillance and partner services investigations undertaken when cases are first reported or, if the individual has not had a laboratory in a 12-month period, through an investigation undertaken of persons thought to be out of care. Public Health does not collect data on the period of study involvement, so we excluded individuals enrolled in a study at any point.
This study is a secondary data analysis of data collected through public health HIV surveillance, including HIV Incidence and Core HIV Surveillance data sources. HIV Incidence and Core HIV Surveillance comprise the Washington State HIV data system called eHARS. HIV Incidence collects testing data, whereas Core contains demographic and transmission characteristics and laboratory tests. Both sources contain data from medical record abstractions, provider reports, and patient interviews. HIV core surveillance and partner services investigations are substantially integrated in King County, and Public Health attempts to interview all persons with newly diagnosed HIV infection. We defined first HIV diagnosis as the earliest positive HIV diagnostic test result or date of self-reported HIV diagnosis. In the event that these differed by more than 40 days, Public Health staff investigated cases to establish which date was likely to be the more accurate. ), and year of diagnosis (2007 through 2013). CD4 counts more than 6 months after diagnosis were changed to missing due to concern that such values might not be representative of CD4 counts at time of diagnosis.
We calculated estimates of time taken for 50% and 75% of the population to reach viral suppression and created KaplanMeier survival plots to visually present time from HIV diagnosis to viral suppression. Individuals contributed time from their date of HIV diagnosis to the date of initial viral suppression (event). Persons with no laboratory results demonstrating HIV viral suppression who were not known to have left the area or died were censored on the date the analytic dataset was created (June 5, 2015) . Persons who died were censored on the date of their death. Patient deaths are updated in eHARS from the Washington state and King County death certificates, the National Death Index, and the Social Security Death Master File. Persons who migrated out of WA State were censored on the date of their last laboratory test result reported to Public Heath HIV surveillance. We have previously reported our procedures for identifying persons who migrate out of the area. 15 We used log rank testing and Cox proportional hazard regression to evaluate the association of independent variables with time to viral suppression. We decide a priori to include age, sex, exposure category, race/ethnicity, CD4 count at diagnosis, and year of diagnosis in the multivariable model of the association of independent variables with time to viral suppression. To address the lack of laboratory completeness validation 2007-2009, we repeated analysis for the 3 years with greater than 90% laboratory completeness (2011-2013). We also conducted a secondary multivariable 
RESULTS
Between 2007 and 2013, 1841 persons were newly diagnosed as having HIV infection in King County, WA. We excluded 56 persons who were enrolled in research studies and 19 persons younger than 14 years from further analysis, leaving a study population of 1766 persons (96% of persons newly diagnosed as having HIV during the study period). A total of 140 (8%) people did not have a CD4 lymphocyte count reported to Public Health in the first 6 months after HIV diagnoses; these persons were excluded from analyses that included CD4 count as an independent variable.
The population was predominantly non-Hispanic white (59%), 25 to 44 years of age (59%), and composed of MSM (76% including 8% MSM-IDU; Table 2 ). Of those with CD4 lymphocyte counts done within 6 months of diagnosis, 45% had less than 350 cells/mm 3 . Although some demographic, clinical, and risk characteristics varied year-to-year, we did not observe significant changes in trends of the characteristics of the newly HIVdiagnosed population.
The 1766 newly diagnosed persons included in the study population achieved viral suppression or were censored in a median time of 258 days (0-3063 days) with an average of 3 viral loads per year before suppression. Of the 276 (16%) who were censored without achieving viral suppression, 36 (13%) died, 86 (31%) moved out of the state, 56 (20%) were still in care with laboratory results reported to surveillance in the final year of study observation (June 2014 or later), and 98 (36%) had no laboratory test results reported in surveillance in the final year of study observation and were not known to have moved out of state or died. This indicates roughly 9% (154 persons) of our initial population never achieved viral suppression, including those who seemed to be out of care as of June 2015 (i.e., no laboratory results reported in the 12 months before the end of observation).
A total of 1490 (84%) persons achieved viral suppression in a median time of 213 days (95% confidence interval [CI], 203-229) after HIV diagnosis. In 2007, half of newly diagnosed persons had achieved viral suppression by 685 days after diagnosis. In contrast, by 2013, half of all newly diagnosed persons were virally suppressed 142 days after diagnosis. In 2007, 36% of all persons diagnosed were virally suppressed within the first 12 months after HIV diagnosis, whereas in 2013, 77% were suppressed 12 months after HIV diagnosis (P < 0.0001).
Trends in time from HIV diagnosis to viral suppression varied by initial CD4 lymphocyte count, although all groups did see a significant decrease in time to suppression over this period ( On univariate analysis, more rapid viral suppression was significantly associated with unknown HIV risk, IDU, or heterosexual transmission categories, female sex, CD4 lymphocyte count less than 500 cells/mm 3 , older age, being a foreign-born black, and later year of HIV diagnosis (Table 3 and Fig. 2) . On multivariable analysis, lower CD4 count, older age, female sex, and more recent year of diagnosis were all significantly associated with more rapid viral suppression (Table 4 [also see Table, Supplemental Digital Content 3, http://links.lww.com/OLQ/A122, multivariable analysis with alternative CD4 groupings]). Similar associations were seen when restricting the analysis to those without CD4 counts at diagnosis (see Table, Supplemental Digital Content 4, http://links.lww.com/OLQ/A123, multivariate analysis for those without CD4 counts). Multivariable analysis restricted to 2011, 2012, and 2013 showed minimal differences in variables associated with time to viral suppression (see Table, Supplemental Digital Content 5, http://links.lww.com/OLQ/A124, multivariable analysis restricted to [2011] [2012] [2013] ). An analysis excluding 19 elite controllers with viral loads less than 50 copies/mL did not significantly change the multivariable adjusted hazard ratio (HR adj ) findings (data not shown).
DISCUSSION
Evaluating King County, WA, HIV surveillance data, we found that the median time from diagnosis to viral load suppression declined 79% for individuals diagnosed between 2007 and 2013, and the decline was most pronounced among persons diagnosed as having higher CD4 counts. We observed no significant indication of racial disparities in time to suppression. These findings highlight the success of one US urban area in instituting early initiation of ART. Further studies are needed to elucidate whether provider prescribing practices or other local implementation factors (funding, political climate, patient awareness, access to medication and the health care system, etc) are primarily responsible for early ART initiation. Our findings have favorable implications related to the clinical outcomes among persons living with HIV/AIDS and HIV transmission. 16 Although much of the change in time to viral suppression is likely a consequence of changes in clinical practice prompted by changes in US national ART guidelines, our findings suggest that guideline changes alone do not entirely explain the dramatic increase in how quickly patients became virally suppressed. Stratifying by CD4 count, we found that the time to viral suppression among persons with the highest CD4 counts clearly declined before the 2012 change in HIV treatment guidelines recommending that all persons with HIV receive ART. This finding demonstrates that clinical practice favoring earlier initiation of ART, at least in King County, WA, changed well in advance of national treatment guidelines.
Prior studies from San Francisco and New York City (NYC) evaluated trends in time from diagnosis to viral load suppression. Investigators in San Francisco found that the median time to virologic suppression decreased roughly 69% between 2004 and 2009, from 32 months (~960 days) to 10 months (~300 days). 17 In NYC, persons suppressed (defined as viral load <400 copies/mL) 12 months after diagnoses increased from 36% in 2006 to 45% in 2009, with the most rapid viral suppression occurring among persons with the lowest CD4 lymphocyte counts (0-199 cells/mm 3 ). 18 The pattern of viral suppression in King County in 2009 was very similar to that reported in NYC and San Francisco; in 2009, the median time to viral suppression in King County was 363 days, and 50% of persons suppressed within the first 12 months after diagnosis. Our more recent data demonstrate that viral suppression now occurs much more quickly after HIV diagnosis. That older data from King County are so similar to findings in other cities suggests that our more recent data may be reflective of patterns of viral suppression occurring in at least some other US cities. After adjusting for calendar year and CD4 count at time of HIV diagnosis, the only factor significantly associated with a lower likelihood of viral suppression was younger age. This finding highlights the need to focus particular attention on young persons with HIV, but also demonstrates our area's success in avoiding significant racial or ethnic disparities in ensuring that persons with HIV receive the care they need after HIV diagnosis. Nationally, blacks are less likely to be virally suppressed than whites, and reducing HIV-related disparities is a critical component of the National HIV/AIDS Strategy. 19, 20 Our findings are good evidence that such disparities can be mitigated, at least in the initial period after HIV diagnosis.
Our study has several limitations. Laboratory reporting improved over the study period, and more complete ascertainment of viral suppression, rather than a true change in virologic outcomes, may have contributed to our findings. Although this change in surveillance data quality could have affected data from earlier years of observation, we believe that changes in data completeness are unlikely to have affected our more recent data. Viral load reporting completeness increased from 86% in 2010 to 93% in 2011 and has subsequently stayed high. 21 Because of an administrative censoring date of June 5, 2015 , it is also possible that very recent laboratories were missed, although this impact should be small due to high levels of suppression before this date. Surveillance data could also be limited by missing or inaccurate dates of HIV diagnosis. However, all new HIV diagnoses in King County are investigated through medical record reviews and, when possible, interviews with patients conducted as part of HIV partner services, and date of HIV diagnosis reflects the results of these comprehensive efforts. We may also be unaware of individuals enrolled in studies, although through initial interviews and follow-up with providers when laboratories are missing, missing study information should be minimized. Our team would not have ascertained viral suppression among persons who left WA State after HIV diagnosis. When looking at the total population of persons living with HIV/AIDS, migration leads to substantial underestimates of population-level viral suppression. 11 This limitation is likely less important when evaluating outcomes in the period immediately after HIV diagnosis, but could have led to an underestimate of viral suppression in our data. We defined time to viral suppression using the date of first HIV RNA test demonstrating viral suppression. The true time to viral suppression is clearly somewhat shorter than this date. Thus, our findings are conservative. Finally, because it was not possible to include specific drug regimen used as an independent variable in our analysis, we cannot assess the extent to which more rapid viral suppression may have been a consequence of use of drug regimens that more quickly achieve viral suppression.
In summary, we found that the time from HIV diagnosis to viral suppression dramatically declined between 2007 and 2013; that the median time from diagnosis to documented viral suppression in King County, WA, in 2013 was 142 days; and that 77% persons in the area in 2013 were virally suppressed within 1 year of HIV diagnosis. Although additional efforts to further shorten this period between diagnosis and effective treatment may be worthwhile, our findings demonstrate that most persons with HIV in our area rapidly achieve the goals of HIV treatment after initial diagnosis. In areas like ours, efforts to minimize the morbidity associated with HIV and diminish transmission should focus on ensuring that HIV diagnoses occur as quickly as possible after infection and promoting the effective treatment for the minority of persons who fail to achieve viral suppression. 
